Last 12 months
Inside the activity.
5 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 4 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 06, 2023 Filed Jan 9, 2023 22:13 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 2,698 | $0.00 Strike: $8.99 | $0.00 |
DisclosureSEC source: 0001209191-23-002593 · doc4.xml · derivative · entry 6 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,717 Underlying: Common Stock · 2,698 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vested on September 14, 2021. Read SEC document |
| January 06, 2023 Filed Jan 9, 2023 22:13 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 2,698 | $15.46 | $41,701.64 |
DisclosureSEC source: 0001209191-23-002593 · doc4.xml · nonDerivative · entry 4 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,426 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $15.40 to $15.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| January 06, 2023 Filed Jan 9, 2023 22:13 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 2,698 | $8.99 | $24,255.02 |
DisclosureSEC source: 0001209191-23-002593 · doc4.xml · nonDerivative · entry 3 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,124 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 22:13 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 2,698 | $0.00 Strike: $8.99 | $0.00 |
DisclosureSEC source: 0001209191-23-002593 · doc4.xml · derivative · entry 5 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,415 Underlying: Common Stock · 2,698 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vested on September 14, 2021. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 22:13 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 2,698 | $15.51 | $41,845.44 |
DisclosureSEC source: 0001209191-23-002593 · doc4.xml · nonDerivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,426 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $15.44 to $15.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 22:13 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 2,698 | $8.99 | $24,255.02 |
DisclosureSEC source: 0001209191-23-002593 · doc4.xml · nonDerivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,124 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 21:27 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 5,398 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-061925 · doc4.xml · derivative · entry 6 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,113 Underlying: Common Stock · 5,398 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 21:27 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 5,398 | $16.82 | $90,807.32 |
DisclosureSEC source: 0001209191-22-061925 · doc4.xml · nonDerivative · entry 4 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,426 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $16.72 to $17.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 21:27 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 5,398 | $4.49 | $24,237.02 |
DisclosureSEC source: 0001209191-22-061925 · doc4.xml · nonDerivative · entry 3 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,824 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| December 16, 2022 Filed Jan 9, 2023 22:13 UTC Amendment |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 887 | $0.00 Strike: $8.99 | $0.00 |
DisclosureSEC source: 0001209191-23-002592 · doc4a.xml · derivative · entry 4 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,113 Underlying: Common Stock · 887 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on January 31, 2020 and vested on September 14, 2021. Read SEC document |
| December 16, 2022 Filed Jan 9, 2023 22:13 UTC Amendment |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 4,511 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-23-002592 · doc4a.xml · derivative · entry 3 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,000 Underlying: Common Stock · 4,511 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31 of each of 2021, 2022, 2023, and 2024. Read SEC document |
| December 16, 2022 Filed Jan 9, 2023 22:13 UTC Amendment |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 887 | $8.99 | $7,974.13 |
DisclosureSEC source: 0001209191-23-002592 · doc4a.xml · nonDerivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,824 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| December 16, 2022 Filed Jan 9, 2023 22:13 UTC Amendment |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 4,511 | $4.49 | $20,254.39 |
DisclosureSEC source: 0001209191-23-002592 · doc4a.xml · nonDerivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,937 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:08 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionOptions (Right to buy) · Derivative | 18,750 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-22-061649 · doc4.xml · derivative · entry 6 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,851 Underlying: Common Stock · 18,750 shares Expires 2026-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on December 30, 2016 and vested on September 14, 2021. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:08 UTC |
Shaker BenjaminChief Markets Officer
|
SaleCommon Stock | 18,750 | $17.26 | $323,662.50 |
DisclosureSEC source: 0001209191-22-061649 · doc4.xml · nonDerivative · entry 4 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,625 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $16.99 to $17.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:08 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionCommon Stock | 18,750 | $3.00 | $56,250.00 |
DisclosureSEC source: 0001209191-22-061649 · doc4.xml · nonDerivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 21:27 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 5,398 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-061925 · doc4.xml · derivative · entry 5 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,511 Underlying: Common Stock · 5,398 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 21:27 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 5,398 | $17.42 | $94,012.65 |
DisclosureSEC source: 0001209191-22-061925 · doc4.xml · nonDerivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,426 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.39 to $17.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 21:27 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 5,398 | $4.49 | $24,237.02 |
DisclosureSEC source: 0001209191-22-061925 · doc4.xml · nonDerivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,824 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 21:08 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionOptions (Right to buy) · Derivative | 18,750 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-22-061649 · doc4.xml · derivative · entry 5 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,601 Underlying: Common Stock · 18,750 shares Expires 2026-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on December 30, 2016 and vested on September 14, 2021. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 21:08 UTC |
Shaker BenjaminChief Markets Officer
|
SaleCommon Stock | 18,750 | $17.52 | $328,490.63 |
DisclosureSEC source: 0001209191-22-061649 · doc4.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,625 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.32 to $18.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 21:08 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionCommon Stock | 18,750 | $3.00 | $56,250.00 |
DisclosureSEC source: 0001209191-22-061649 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| December 06, 2022 Filed Dec 7, 2022 21:13 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 5,398 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-060145 · doc4.xml · derivative · entry 6 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,909 Underlying: Common Stock · 5,398 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| December 06, 2022 Filed Dec 7, 2022 21:13 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 5,398 | $17.72 | $95,631.51 |
DisclosureSEC source: 0001209191-22-060145 · doc4.xml · nonDerivative · entry 4 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,426 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.69 to $17.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| December 06, 2022 Filed Dec 7, 2022 21:13 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 5,398 | $4.49 | $24,237.02 |
DisclosureSEC source: 0001209191-22-060145 · doc4.xml · nonDerivative · entry 3 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,824 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| December 05, 2022 Filed Dec 7, 2022 21:13 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 5,398 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-060145 · doc4.xml · derivative · entry 5 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290,307 Underlying: Common Stock · 5,398 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| December 05, 2022 Filed Dec 7, 2022 21:13 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 5,398 | $17.80 | $96,079.00 |
DisclosureSEC source: 0001209191-22-060145 · doc4.xml · nonDerivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,426 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.72 to $17.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| December 05, 2022 Filed Dec 7, 2022 21:13 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 5,398 | $4.49 | $24,237.02 |
DisclosureSEC source: 0001209191-22-060145 · doc4.xml · nonDerivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,824 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| November 18, 2022 Filed Nov 22, 2022 16:04 UTC |
Sell StevenDirector · CEO & President
|
PurchaseCommon Stock | 2,900 | $17.14 | $49,704.55 |
DisclosureSEC source: 0001209191-22-058341 · doc4.xml · nonDerivative · entry 1 Sell Steven · CIK 0001479123 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 2,900 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $17.12 to $17.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. F2 · ownership.nature: These shares of common stock are held in the Steven J. Sell and Margaret D. Williams Revocable Inter Vivos Trust Agreement. Read SEC document |
| November 17, 2022 Filed Nov 18, 2022 21:50 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionOptions (Right to buy) · Derivative | 18,750 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-22-057871 · doc4.xml · derivative · entry 6 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,351 Underlying: Common Stock · 18,750 shares Expires 2026-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on December 30, 2016 and vested on September 14, 2021. Read SEC document |
| November 17, 2022 Filed Nov 18, 2022 21:50 UTC |
Shaker BenjaminChief Markets Officer
|
SaleCommon Stock | 18,750 | $17.17 | $321,956.25 |
DisclosureSEC source: 0001209191-22-057871 · doc4.xml · nonDerivative · entry 4 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,625 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $16.60 to $17.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| November 17, 2022 Filed Nov 18, 2022 21:50 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionCommon Stock | 18,750 | $3.00 | $56,250.00 |
DisclosureSEC source: 0001209191-22-057871 · doc4.xml · nonDerivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| November 17, 2022 Filed Nov 18, 2022 21:50 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 5,396 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-057870 · doc4.xml · derivative · entry 6 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,705 Underlying: Common Stock · 5,396 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| November 17, 2022 Filed Nov 18, 2022 21:50 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 5,396 | $17.43 | $94,054.98 |
DisclosureSEC source: 0001209191-22-057870 · doc4.xml · nonDerivative · entry 4 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,426 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.34 to $17.505, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| November 17, 2022 Filed Nov 18, 2022 21:50 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 5,396 | $4.49 | $24,228.04 |
DisclosureSEC source: 0001209191-22-057870 · doc4.xml · nonDerivative · entry 3 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 21:50 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionOptions (Right to buy) · Derivative | 18,750 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-22-057871 · doc4.xml · derivative · entry 5 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,101 Underlying: Common Stock · 18,750 shares Expires 2026-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on December 30, 2016 and vested on September 14, 2021. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 21:50 UTC |
Shaker BenjaminChief Markets Officer
|
SaleCommon Stock | 18,750 | $18.29 | $343,008.75 |
DisclosureSEC source: 0001209191-22-057871 · doc4.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,625 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.91 to $18.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 21:50 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionCommon Stock | 18,750 | $3.00 | $56,250.00 |
DisclosureSEC source: 0001209191-22-057871 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 21:50 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 5,396 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-057870 · doc4.xml · derivative · entry 5 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,101 Underlying: Common Stock · 5,396 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 21:50 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 5,396 | $18.52 | $99,918.81 |
DisclosureSEC source: 0001209191-22-057870 · doc4.xml · nonDerivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,426 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $18.37 to $18.815, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 21:50 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 5,396 | $4.49 | $24,228.04 |
DisclosureSEC source: 0001209191-22-057870 · doc4.xml · nonDerivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 20:05 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 5,396 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-055490 · doc4.xml · derivative · entry 6 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,497 Underlying: Common Stock · 5,396 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 20:05 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 5,396 | $19.53 | $105,407.08 |
DisclosureSEC source: 0001209191-22-055490 · doc4.xml · nonDerivative · entry 4 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,426 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.43 to $19.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 20:05 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 5,396 | $4.49 | $24,228.04 |
DisclosureSEC source: 0001209191-22-055490 · doc4.xml · nonDerivative · entry 3 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:05 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 5,396 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-055490 · doc4.xml · derivative · entry 5 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,893 Underlying: Common Stock · 5,396 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:05 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 5,396 | $20.03 | $108,093.21 |
DisclosureSEC source: 0001209191-22-055490 · doc4.xml · nonDerivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,426 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.94 to $20.26, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:05 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 5,396 | $4.49 | $24,228.04 |
DisclosureSEC source: 0001209191-22-055490 · doc4.xml · nonDerivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| October 20, 2022 Filed Oct 22, 2022 00:52 UTC Amendment |
Shaker BenjaminChief Markets Officer
|
SaleCommon Stock | 1,500 | $20.66 | $30,991.05 |
DisclosureSEC source: 0001209191-22-054346 · doc4a.xml · nonDerivative · entry 4 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,625 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.64 to $20.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes restricted stock units. F4 · balance_after: The total was decreased by 1,507 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| October 20, 2022 Filed Oct 22, 2022 00:52 UTC Amendment |
Shaker BenjaminChief Markets Officer
|
SaleCommon Stock | 28,048 | $20.35 | $570,844.12 |
DisclosureSEC source: 0001209191-22-054346 · doc4a.xml · nonDerivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,125 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.64 to $20.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes restricted stock units. F4 · balance_after: The total was decreased by 1,507 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| October 20, 2022 Filed Oct 21, 2022 20:09 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionOptions (Right to buy) · Derivative | 29,548 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-22-054260 · doc4.xml · derivative · entry 8 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,851 Underlying: Common Stock · 29,548 shares Expires 2026-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These options were granted on December 30, 2016 and vested on September 14, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.